Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
about
Current issues on safety of prokinetics in critically ill patients with feed intoleranceOnce-daily cefazolin and probenecid for skin and soft tissue infectionsCefepimeThe Mark Coventry Award: Higher tissue concentrations of vancomycin with low-dose intraosseous regional versus systemic prophylaxis in TKA: a randomized trialPharmacokinetic and pharmacodynamic modeling of cyadox against Clostridium perfringens in swine.Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectivesResistance among Streptococcus pneumoniae: Implications for drug selection.Veterinary drug usage and antimicrobial resistance in bacteria of animal origin.Pharmacokinetic and Pharmacodynamic Integration and Modeling of Enrofloxacin in Swine for Escherichia coli.Integration of pharmacokinetic and pharmacodynamic indices of orbifloxacin in beagle dogs after a single intravenous and intramuscular administration.Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa.Pharmacological therapy of feed intolerance in the critically ills.Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against Escherichia coli in Pigs.Effects of various antibiotics alone or in combination with doripenem against Klebsiella pneumoniae strains isolated in an intensive care unit.Pharmacological treatment for infectious corneal ulcers.Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.PK-PD Analysis of Marbofloxacin against Streptococcus suis in Pigs.Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa.PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs.The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against Haemophilus parasuis.Factors affecting gentamicin penetration in lower extremity ischemic tissues with ulcers.
P2860
Q26992006-54458257-4C15-434C-A3F2-7D9CD8266BFDQ28245769-24B52983-8B94-4FB3-B4A8-9EED7E047171Q29040262-61E272F5-543D-438A-AF36-DF8F854C712EQ30564105-A9E013DF-43B5-4515-B6CC-AED05230F5CCQ33826396-95C779E3-7865-4039-B463-693B2560304DQ33981379-82E382A6-1542-4616-914F-DC22A8ED9599Q34632445-2E50A847-5814-47E2-83DF-8FE909D05139Q34658646-7B1B566E-9F8E-445E-AEF9-23A03C0F1FA2Q36065193-2D5A96ED-73BC-4E1C-BC18-AFDDA19F0D34Q36527295-83BAB7B7-23A2-4CDA-9730-0BA65BCF538FQ37247584-E96520DE-3A28-4517-8938-B6274E1C1323Q37734296-1E7DFA95-0DF2-4262-A47D-C4339507EC9AQ38240886-553C81D3-F4AD-48F5-85C9-15CFAADBA484Q41484913-D4A9E7F1-E50B-4FEF-82CD-ADF6B94F95CFQ41587703-37315C67-517E-4882-8FFF-0170E3C41C66Q42273313-B193365C-A2CC-4E3A-8A8F-8FC69C5433DEQ46921577-326E32A8-92A1-4B36-86D9-B62859F681DFQ47362352-B67D3982-4E03-41EF-B965-008AEBA3D2BAQ47609526-C1E2F179-D23D-416C-8095-587DA9E59FF7Q47701094-E63E396F-FCAC-458D-9783-69F5388DCAE7Q49210057-AEE5178D-4A3A-4E9A-A94B-B185A6731D5DQ51423932-A94D4926-D1B1-448C-A2C1-C7B10DAEF99B
P2860
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
@ast
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
@en
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
@nl
type
label
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
@ast
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
@en
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
@nl
prefLabel
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
@ast
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
@en
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
@nl
P1433
P1476
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
@en
P2093
Burgess DS
P304
P356
10.1378/CHEST.115.SUPPL_1.19S
P407
P433
P577
1999-03-01T00:00:00Z